{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:43:08Z","timestamp":1787787788989,"version":"build-2784847793"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,29]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Hypophosphatemic osteomalacia is a rare chronic metabolic bone disease characterized by low serum phosphate levels owing to genetic or acquired causes. This article presents a case report of the clinical management, challenges encountered, and prognosis of secondary hypophosphatemic osteomalacia induced by defovir and tenofovir.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 55-year-old male patient had been experiencing persistent dull chest pain and fatigue for more than a year. The patient had chronic hepatitis B infection for over 10 years, with regular use of adefovir dipivoxil capsules for more than 10 years. Five months before admission, the patient was switched to tenofovir alafenamide fumarate tablets.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>After obtaining clinical manifestations, medical history, and examination results, tumor-induced osteomalacia was excluded, and the final diagnosis was drug-induced hypophosphatemic osteomalacia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Adefovir dipivoxil and tenofovir alafenamide were discontinued, and the patient was switched to entecavir disintegration tablets for antiviral therapy. He was advised to follow a high-phosphate diet, receive phosphorus supplementation and calcitriol capsules to promote calcium absorption, obtain moderate sun exposure, and take measures to prevent falls and fractures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Serum phosphate levels showed a gradual upward trend, with the most recent measurement being 0.85 mmol\/L. The bone density gradually improved and reached normal levels in the most recent assessment. The symptoms of fatigue and chest pain were resolved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Accurate diagnosis requires a combination of clinical presentation, medical history, biochemical and radiological findings, and, if available, measurement of fibroblast growth factor 23 (FGF 23). The role of national, provincial, or regional centers for rare diseases is crucial for conducting unconventional tests and providing access to rare medications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040746","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T21:02:38Z","timestamp":1732914158000},"page":"e40746","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Clinical management of hypophosphatemic osteomalacia induced by adefovir and tenofovir: Insights from a case report"],"prefix":"10.1097","volume":"103","author":[{"given":"Yinhui","family":"He","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Lishui Central Hospital, the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Lishui Central Hospital, the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Radiology, Lishui Central Hospital, the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Lishui Central Hospital, the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","first-page":"267","article-title":"Guideline for the diagnosis and management of hypophosphatemic rickets\/osteomalacia.","volume":"38","author":"Xu","year":"2022","journal-title":"Chin J Endocrinol Metab"},{"key":"R2-20250503","first-page":"203","article-title":"A case of nucleoside drug-induced secondary fanconi syndrome, hypophosphatemic osteomalacia, and concurrent parathyroid hormone deficiency.","volume":"40","author":"Wang","year":"2023","journal-title":"J Clin Intern Med"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1016\/j.amjmed.2020.03.020","article-title":"Hypophosphatemic osteomalacia due to adefovir-induced fanconi syndrome.","volume":"133","author":"Leungsuwan","year":"2020","journal-title":"Am J Med"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"e10374","DOI":"10.1002\/jbm4.10374","article-title":"Bisphosphonate-Induced deterioration of osteomalacia in undiagnosed adult fanconi syndrome.","volume":"4","author":"Cundy","year":"2020","journal-title":"JBMR Plus"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/0960327118802619","article-title":"Mitochondrial pathway of apoptosis and necrosis contribute to tenofovir disoproxil fumarate induced renal damage in rats.","volume":"38","author":"Ramamoorthy","year":"2018","journal-title":"Hum Exp Toxicol"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"46344","DOI":"10.1038\/srep46344","article-title":"Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit b to metabolically reprogram glucose metabolism and induce nephrotoxicity.","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci Rep"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5371\/hp.2018.30.2.109","article-title":"An uncommon case of bilateral pathologic hip fractures: antiviral drug-induced osteomalacia in a patient with hepatitis B.","volume":"30","author":"Moon","year":"2018","journal-title":"Hip Pelvis"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/aid.2011.0052","article-title":"Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir.","volume":"28","author":"Masia","year":"2011","journal-title":"AIDS Res Hum Retrov"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1128\/AAC.01096-13","article-title":"Association of higher plasma vitamin d binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin d deficiency?","volume":"57","author":"Havens","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.biopha.2017.11.037","article-title":"High parathyroid hormone concentration in tenofovir-treated patients are due to inhibition of calcium-sensing receptor activity.","volume":"97","author":"Mingione","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"1043954","DOI":"10.3389\/fendo.2022.1043954","article-title":"Tenofovir-induced osteopenia and hyperparathyroidism: a case report and literature review.","volume":"13","author":"Zeng","year":"2023","journal-title":"Front Endocrinol"},{"key":"R12-20250503","first-page":"447","article-title":"Reflections on studying the \u201cGuideline for the diagnosis and management of hypophosphatemic rickets\/osteomalacia\u201d.","volume":"15","author":"Meng","year":"2022","journal-title":"J Chin Osteoporos Miner Dis"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.eprac.2022.07.005","article-title":"Hypophosphatemia: a practical guide to evaluation and management.","volume":"28","author":"Tebben","year":"2022","journal-title":"Endocr Pract"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13256-019-2018-7","article-title":"Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report.","volume":"13","author":"Kunii","year":"2019","journal-title":"J Med Case Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:02:49Z","timestamp":1746316969000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":14,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040746","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]}}}